Navigation Links
Treatment Of Brain Aneurysms By A New Non-Surgical Approach

Aneurysm refers to a sac formed by localized dilation of the wall of an artery, a vein or the heart. A brain aneurysm arises as a result of weakness in the arterial wall of the brain. Rupture of the aneurysm can result in // stroke or death.

A new approach combining the use of intracranial stents and coil embolization to strengthen the artery has been proposed as a treatment for the condition. It also saves the trouble of a complicated surgery that would involve opening of the skull.

Coil embolization is a procedure in which tiny coils are used to close off the aneurysm. A catheter inserted into the femoral artery (a blood vessel in the upper leg) is used to deliver the coils to the aneurysm in the blood vessels of the brain. The procedure is not without limitations.

Coil embolization is currently used to treat approximately 30 percent of cerebral aneurysms. The procedure is less invasive and requires significantly less recovery time than open surgery for aneurysm repair. Additional benefits include minimal blood loss and the option for local anesthesia.

If the aneurysm was more than 4mm, the "wide neck" of the aneurysm prevented the coil from staying in place on its own and the aneurysm was very likely to return.

The introduction of flexible intracranial stents has provided an answer to retaining stents within the aneurysm, thereby preventing recurrence. This provides minimally invasive option for repairing of cerebral aneurysms. Furthermore, the procedure has been found to be very effective in 90% of the cases, resulting in complete closure of the aneurysm without compromising the parent vessel at least six months after the procedure.

"Our results are encouraging because they demonstrate that devices like the intracranial stent will continue to not only improve our ability to treat challenging wide-necked aneurysms without opening the skull but also to have a significant impact on re-treatment rate s" said Lopes, one of the experts in the field.
'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology: